More than 80 pharmaceutical companies have called on governments to develop new ways of paying them to develop antibiotics. With drug-resistant microbes predicted to kill 10 million people a year by 2050 and cost $100 trillion in lost economic output, Redx Pharm chief executive said “there is a doomsday clock ticking, with the effectiveness of antibiotics diminishing at an alarming rate, new ways must be found to support innovation and drug discovery in this critical area”.

CDC to spend $2.1B to bolster US infection control and prevention efforts

Becker’s Hospital Review recently reported on...

Nuestro reloj biológico juega un papel crucial en la curación de la cirugía.

Según un estudio compartido por ScienceDaily,...

Still not enough antibiotics in the works to fight superbugs, WHO says

In a new report shared by Becker’s Hospital...

Ontario scientist thinks old drugs could become our new antibiotics

As the world loses its upper hand in the...

By changing their shape, some bacteria can grow more resilient to antibiotics

ScienceDaily recently reported on new research...

COVID-19 cited in significant increase in healthcare-associated infections in 2020

According to ScienceDaily, a CDC analysis of...

Surgery and scan backlogs set to worsen without government funding, CMA says

As the world enters the second wave of COVID-19,...

Global antibiotic consumption rates have increased by 46 percent since 2000

According to a new study recently shared by...

Distribuidor exclusivo.

0